Key result
Lab-confirmed influenza in China is associated with a higher average economic burden compared to influenza-like illness, with the heaviest direct medical burden in hospitalized patients aged ≥60 years.
Systematic Review
Lab-confirmed influenza and older age (60+ years) are associated with a higher economic burden in China.
Higher burden in lab-confirmed cases and hospitalized adults ≥60 may prioritize prevention; extends economic data for influenza policy in China.
The average economic burden of lab-confirmed influenza case is higher than that of influenza-like illness, and there are differences in outpatient indirect expenses and inpatients direct medical expenses. The direct medical burden for the hospitalized 60-years-and-beyond influenza case group is heavier thar other age group. By region, the influenza associated individual economic burden in rural area is higher than that of urban area..
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2019) conducted a systematic review in Influenza. Lab-confirmed influenza vs. Influenza-like illness was evaluated on Economic burden. Lab-confirmed influenza in China is associated with a higher average economic burden compared to influenza-like illness, with the heaviest direct medical burden in hospitalized patients aged ≥60 years.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: